Ex vivo organ perfusion is a technique used in transplantation and research to preserve and evaluate organs outside of the body before transplantation. During ex vivo perfusion, the organ is connected to a perfusion system that delivers oxygenated blood or a specialized preservation solution to maintain the organ's viability and function. This process allows for the assessment and optimization of organ function, as well as the potential for organ repair or treatment prior to transplantation. Ex vivo organ perfusion offers several advantages over traditional static cold storage, including the ability to assess organ viability, reduce ischemic injury, and potentially expand the donor pool by allowing for the use of marginal or extended criteria organs. Additionally, ex vivo perfusion enables researchers to study organ physiology, test new therapies, and improve transplantation outcomes.
The global Ex Vivo Organ Perfusion Service market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The “Ex Vivo Organ Perfusion Service Industry Forecast” looks at past sales and reviews total world Ex Vivo Organ Perfusion Service sales in 2022, providing a comprehensive analysis by region and market sector of projected Ex Vivo Organ Perfusion Service sales for 2023 through 2029. With Ex Vivo Organ Perfusion Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ex Vivo Organ Perfusion Service industry.
This Insight Report provides a comprehensive analysis of the global Ex Vivo Organ Perfusion Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Ex Vivo Organ Perfusion Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Ex Vivo Organ Perfusion Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ex Vivo Organ Perfusion Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ex Vivo Organ Perfusion Service.
United States market for Ex Vivo Organ Perfusion Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Ex Vivo Organ Perfusion Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Ex Vivo Organ Perfusion Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Ex Vivo Organ Perfusion Service players cover TransMedics, Lung Bioengineering, OrganOx, XVIVO, TNO, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Ex Vivo Organ Perfusion Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
Heart Perfusion
Liver Perfusion
Kidney Perfusion
Lung Perfusion
Segmentation by Application:
Organ Transplant Specialist Hospitals
Organ Banks
Pharmaceutical Research Organizations
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Heart Perfusion
Liver Perfusion
Kidney Perfusion
Lung Perfusion
Segmentation by Application:
Organ Transplant Specialist Hospitals
Organ Banks
Pharmaceutical Research Organizations
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
TransMedics
Lung Bioengineering
OrganOx
XVIVO
TNO
UHN
SCREEN
Bridge to Life
Organ Recovery Systems
Institut Georges Lopez
Ebers
Penn Medicine
Johns Hopkins Medicine
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Ex Vivo Organ Perfusion Service Market Size 2025-2030
2.1.2 Ex Vivo Organ Perfusion Service Market Size CAGR by Region
2.2 Ex Vivo Organ Perfusion Service Segment by Type
2.2.1 Heart Perfusion
2.2.2 Liver Perfusion
2.2.3 Kidney Perfusion
2.2.4 Lung Perfusion
2.3 Ex Vivo Organ Perfusion Service Market Size by Type
2.3.1 Global Ex Vivo Organ Perfusion Service Market Size Market Share by Type (2025-2030)
2.3.2 Global Ex Vivo Organ Perfusion Service Market Size Growth Rate by Type (2025-2030)
2.4 Ex Vivo Organ Perfusion Service Segment by Application
2.4.1 Organ Transplant Specialist Hospitals
2.4.2 Organ Banks
2.4.3 Pharmaceutical Research Organizations
2.5 Ex Vivo Organ Perfusion Service Market Size by Application (2025-2030)
2.5.1 Global Ex Vivo Organ Perfusion Service Market Size Market Share by Application (2025-2030)
2.5.2 Global Ex Vivo Organ Perfusion Service Market Size Growth Rate by Application (2025-2030)
3 Ex Vivo Organ Perfusion Service Key Players
3.1 Date of Key Players Enter into Ex Vivo Organ Perfusion Service
3.2 Key Players Ex Vivo Organ Perfusion Service Product Offered
3.3 Key Players Ex Vivo Organ Perfusion Service Funding/Investment Analysis
3.4 Funding/Investment
3.4.1 Funding/Investment by Regions
3.4.2 Funding/Investment by End-Industry
3.5 Key Players Ex Vivo Organ Perfusion Service Valuation & Market Capitalization
3.6 Key Players Mergers & Acquisitions, Expansion Plans
3.7 Market Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions
4 Ex Vivo Organ Perfusion Service by Regions
4.1 Ex Vivo Organ Perfusion Service Market Size by Regions (2025-2030)
4.2 United States Ex Vivo Organ Perfusion Service Market Size Growth (2025-2030)
4.3 China Ex Vivo Organ Perfusion Service Market Size Growth (2025-2030)
4.4 Europe Ex Vivo Organ Perfusion Service Market Size Growth (2025-2030)
4.5 Rest of World Ex Vivo Organ Perfusion Service Market Size Growth (2025-2030)
5 United States
5.1 United States Ex Vivo Organ Perfusion Service Market Size by Type (2025-2030)
5.2 United States Ex Vivo Organ Perfusion Service Market Size by Application (2025-2030)
6 Europe
6.1 Europe Ex Vivo Organ Perfusion Service Market Size by Type (2025-2030)
6.2 Europe Ex Vivo Organ Perfusion Service Market Size by Application (2025-2030)
7 China
7.1 China Ex Vivo Organ Perfusion Service Market Size by Type (2025-2030)
7.2 China Ex Vivo Organ Perfusion Service Market Size by Application (2025-2030)
8 Rest of World
8.1 Rest of World Ex Vivo Organ Perfusion Service Market Size by Type (2025-2030)
8.2 Rest of World Ex Vivo Organ Perfusion Service Market Size by Application (2025-2030)
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Key Investors in Ex Vivo Organ Perfusion Service
10.1 Company A
10.1.1 Company A Company Details
10.1.2 Company Description
10.1.3 Companies Invested by Company A
10.1.4 Company A Key Development and Market Layout
10.2 Company B
10.2.1 Company B Company Details
10.2.2 Company Description
10.2.3 Companies Invested by Company B
10.2.4 Company B Key Development and Market Layout
10.3 Company C
10.3.1 Company C Company Details
10.3.2 Company Description
10.3.3 Companies Invested by Company C
10.3.4 Company C Key Development and Market Layout
10.4 Company D
10.5 ……
11 Key Players Analysis
11.1 TransMedics
11.1.1 TransMedics Company Details
11.1.2 TransMedics Ex Vivo Organ Perfusion Service Product Offered
11.1.3 TransMedics Ex Vivo Organ Perfusion Service Market Size (2023 VS 2028)
11.1.4 TransMedics Main Business Overview
11.1.5 TransMedics News
11.2 Lung Bioengineering
11.2.1 Lung Bioengineering Company Details
11.2.2 Lung Bioengineering Ex Vivo Organ Perfusion Service Product Offered
11.2.3 Lung Bioengineering Ex Vivo Organ Perfusion Service Market Size (2023 VS 2028)
11.2.4 Lung Bioengineering Main Business Overview
11.2.5 Lung Bioengineering News
11.3 OrganOx
11.3.1 OrganOx Company Details
11.3.2 OrganOx Ex Vivo Organ Perfusion Service Product Offered
11.3.3 OrganOx Ex Vivo Organ Perfusion Service Market Size (2023 VS 2028)
11.3.4 OrganOx Main Business Overview
11.3.5 OrganOx News
11.4 XVIVO
11.4.1 XVIVO Company Details
11.4.2 XVIVO Ex Vivo Organ Perfusion Service Product Offered
11.4.3 XVIVO Ex Vivo Organ Perfusion Service Market Size (2023 VS 2028)
11.4.4 XVIVO Main Business Overview
11.4.5 XVIVO News
11.5 TNO
11.5.1 TNO Company Details
11.5.2 TNO Ex Vivo Organ Perfusion Service Product Offered
11.5.3 TNO Ex Vivo Organ Perfusion Service Market Size (2023 VS 2028)
11.5.4 TNO Main Business Overview
11.5.5 TNO News
11.6 UHN
11.6.1 UHN Company Details
11.6.2 UHN Ex Vivo Organ Perfusion Service Product Offered
11.6.3 UHN Ex Vivo Organ Perfusion Service Market Size (2023 VS 2028)
11.6.4 UHN Main Business Overview
11.6.5 UHN News
11.7 SCREEN
11.7.1 SCREEN Company Details
11.7.2 SCREEN Ex Vivo Organ Perfusion Service Product Offered
11.7.3 SCREEN Ex Vivo Organ Perfusion Service Market Size (2023 VS 2028)
11.7.4 SCREEN Main Business Overview
11.7.5 SCREEN News
11.8 Bridge to Life
11.8.1 Bridge to Life Company Details
11.8.2 Bridge to Life Ex Vivo Organ Perfusion Service Product Offered
11.8.3 Bridge to Life Ex Vivo Organ Perfusion Service Market Size (2023 VS 2028)
11.8.4 Bridge to Life Main Business Overview
11.8.5 Bridge to Life News
11.9 Organ Recovery Systems
11.9.1 Organ Recovery Systems Company Details
11.9.2 Organ Recovery Systems Ex Vivo Organ Perfusion Service Product Offered
11.9.3 Organ Recovery Systems Ex Vivo Organ Perfusion Service Market Size (2023 VS 2028)
11.9.4 Organ Recovery Systems Main Business Overview
11.9.5 Organ Recovery Systems News
11.10 Institut Georges Lopez
11.10.1 Institut Georges Lopez Company Details
11.10.2 Institut Georges Lopez Ex Vivo Organ Perfusion Service Product Offered
11.10.3 Institut Georges Lopez Ex Vivo Organ Perfusion Service Market Size (2023 VS 2028)
11.10.4 Institut Georges Lopez Main Business Overview
11.10.5 Institut Georges Lopez News
11.11 Ebers
11.12 Penn Medicine
11.13 Johns Hopkins Medicine
12 Research Findings and Conclusion
Ěý
Ěý
*If Applicable.
